# BridgeBio Pharma, Inc.: Form DEF 14A, filed Apr 30, 2025

- Company: [BridgeBio Pharma, Inc.](/companies/bbio.md) (CIK 1743881)
- Form: DEF 14A
- Filed: 2025-04-30
- Accepted by EDGAR: Apr 30, 2025, 06:01 ET
- Period: 2025-06-20
- Accession: 0001140361-25-016452
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1743881/000114036125016452/ny20044444x2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1743881/000114036125016452/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1743881/000114036125016452/ny20044444x2_def14a.htm

Filed Apr 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-016452. Last ingested by Listed: Nov 3, 2026, 19:31 ET. No prices; not investment advice.